Crown Holdings Picks Nevada For New Beverage Can Plant
Crown Holdings Inc (NYSE:CCK) stated that its previously announced Southwestern U.S. aluminum beverage can manufacturing facility will be located in Mesquite,…
Truist Securities Initiates Coverage On Crown Holdings with Buy Rating, Announces Price Target of $138
Truist Securities initiates coverage on Crown Holdings (NYSE:CCK) with a Buy rating and announces Price Target of $138.
Return on Capital Employed Insights for Crown Holdings
After pulling data from Benzinga Pro it seems like during Q2, Crown Holdings (NYSE:CCK) earned $385.00 million, a 0.26% increase from the preceding quarter. Crown Holdings's sales decreased to $2.86 billion, a 7.21% change since Q1.
Recap: Crown Holdings Q2 Earnings
Shares of Crown Holdings (NYSE:CCK) increased in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share were up 60.90% year over year to $2.14, which beat the estimate of $1.78.
Crown Holdings Q2 Adj. EPS $2.14 Beats $1.78 Estimate, Sales $2.86B Miss $2.97B Estimate
Crown Holdings (NYSE:CCK) reported quarterly earnings of $2.14 per share which beat the analyst consensus estimate of $1.78 by 20.22 percent. This is a 60.9 percent increase over earnings of $1.33 per share from the same
Earnings Scheduled For July 19, 2021
Companies Reporting Before The Bell
• Bank of Marin (NASDAQ:BMRC) is expected to report quarterly earnings at $0.61 per share on revenue of $24.73 million.
Earnings Outlook For Crown Holdings
Crown Holdings (NYSE:CCK) will be releasing its next round of earnings this Monday, July 19. For all of the relevant information, here is your guide for Monday's Q2 earnings announcement.
A Look Into Crown Holdings Debt
Shares of Crown Holdings (NYSE:CCK) fell by 2.81% in the past three months. Before we understand the importance of debt, let us look at how much debt Crown Holdings has.
Morgan Stanley Maintains Overweight on Crown Holdings, Raises Price Target to $129
Morgan Stanley maintains Crown Holdings (NYSE:CCK) with a Overweight and raises the price target from $122 to $129.